Despite increasing rates of prescription opioid (PO) misuse in adults 50 years of age and older, little research has investigated such misuse in this population. This work aimed to examine sources of misused opioid medication in adults 50 years and older, with comparisons to younger groups. Data were from the 2009 to 2014 National Survey on Drug Use and Health surveys. Prevalence rates of PO sources, misuse, and PO use disorder (POUD) symptoms were estimated. Design-based logistic regression investigated age-based differences in these factors and the association of sources with POUD symptoms and other concurrent substance use. Nearly half (47.7%) of adults 65 years and older used physician sources for past 30-day PO misuse, with the second highest rates in those 50 to 64 years old (39.2%). Conversely, use of theft (5.3%), purchases (8.5%), or friends/family (for free; 23.2%) to obtain opioids were least common in adults 65 years and older, with prevalence rates of these sources in those 50 years and older closer to those of younger groups. Across those 50 years and older, use of purchases, physician, or multiple sources were associated with elevated POUD symptom prevalence. Older adults, particularly those 65 years and older, use a different pattern of PO sources than adolescents or younger adults, and those using physician sources have elevated POUD symptoms. Physicians are a key avenue for older adults to obtain opioids for misuse, highlighting the potential role of clinicians in limiting such misuse.
Introduction
As the "Baby Boomer" generation ages into older adulthood, rates of older adult prescription opioid (PO) misuse and PO use disorders (POUDs) are projected to increase. 7 Perhaps, because younger adult PO misuse rates are much higher, 5 adults 50 years of age and older have not been a focus of PO misuse research. Nonetheless, National Survey on Drug Use and Health (NSDUH 35 ) and poison center data 41 42 and fatal overdose increased by 231% in those 55 years and older over the decade to 2015. 6 These data support Colliver et al. 7 : older adult PO misuse and related consequences have increased.
Older adult PO misuse phenomena are underexplored, with commentators calling for research. 20, 22, 43 Older adults are more likely to experience chronic pain, 12, 21 are prescribed more opioid and other central nervous system depressant medication, and experience more medication-related problems than younger groups. 40 Older adults may have greater PO access for misuse, heightening the likelihood of dangerous interactions with alcohol or other medication. 17, 29, 30 Research could identify older adult PO misuse characteristics to target through policy and prevention, limiting the likelihood of such misuse.
One target could be sources (ie, how medications are obtained) of POs misused by older adults. Adolescents often obtain misused POs from peers or family, 34 whereas young adults use peers more often. 24, 25 National Survey on Drug Use and Health data indicated 2 primary PO sources across the U.S. population: friends or relatives for free (40.5%) and a single physician (34.0%); no other source exceeded 10%. 15 Preliminary research 27 suggested that older adults were more likely to use multiple physician sources than younger groups, but little else is known. Identification of older adult PO sources provides 2 intervention targets: those prescribed POs, as they can receive education on the consequences of PO misuse and diversion; and, individuals using sources associated with greater risk behavior, as they can be targeted for intensive interventions. Evidence from adolescents 34 and young adults 25, 26 suggests that use of purchases or multiple sources is associated with problematic substance use.
Using 2009 to 2014 NSDUH data, this work aimed to quantify PO misuse sources in adults aged 50 years and older, with examination of the 50 to 64 and 65 and older groups separately. Older adults were compared with younger age groups to investigate age-based differences in sources. Further analyses within older adults examined sex differences in sources and the association of specific sources with PO misuse consequences (ie, DSM-5 POUD symptoms 2 ), nonopioid substance use, and substance use disorder (SUD) symptoms. We hypothesized that older adults would make greater use of physician sources than younger groups and that use of multiple PO sources and purchases would be associated with POUD and nonopioid SUD symptoms, given their robust associations in younger groups. 26 ,34
Methods
The NSDUH is representative of the United States at the time of the survey, using an independent, multistage area probability sample for all states and DC. Households are selected for screening, with identification of individuals aged 12 years and older through in-person screening. Full interviews are conducted on a random sample of household members, per sampling area specifications. The NSDUH uses audio computer-assisted selfinterviewing (ACASI) survey methods to ensure privacy and promote data accuracy and completeness, with all sensitive variables (eg, PO misuse) assessed through ACASI. For ACASI questions, the participant wears headphones to hear all questions and the field interviewer remains out of view of the computer screen. The NSDUH includes automatic skip-outs, consistency checks based on previous answers and imputation to increase data completeness and consistency. Imputation occurred in less than 0.25% of cases for lifetime PO misuse, with PO misuse recency (eg, past year and past month) imputed in between 2.5% and 3.1% of those engaged in lifetime PO; PO sources were not imputed. 
Measures
Sociodemographic characteristics included age group, sex, race/ethnicity, and family income. Lifetime PO misuse was assessed through the following question: "Have you ever, even once, used (opioid medication) that was not prescribed for you or that you took only for the experience or feeling it caused?" This question was repeated for a series of common opioid medications (eg, Percocet and Vicodin) and once asking about "any other prescription pain reliever." A "yes" answer to any such question endorsing opioid misuse (ie, without a prescription or solely for the feeling it caused) qualified as lifetime PO misuse. To aid recall, participants are shown pictures of all queried medications and an extensive list of brand and generic names is included. These questions on lifetime PO misuse were preceded by instructions to participants to not include over-the-counter analgesic medication (eg, ibuprofen) use in answers.
Past-year and past-month opioid misuse was assessed in those endorsing lifetime PO misuse through the following question: "How long has it been since you last used any prescription pain reliever that was not prescribed for you or that you took only for the experience or feeling it caused?" (emphasis from the NSDUH). Answers are then coded by NSDUH staff into summary variables for past-year and past-month PO misuse. Lifetime PO misuse has a kappa value of 0.78, and past year has a kappa value of 0.71, with both indicating good reliability. 36 Sources of opioid medication for misuse were assessed by providing a list of 10 specific opioid source options with the question: "how did you get these prescription pain relievers?" Sources were assessed only in those with past-month PO misuse, and participants were asked to select all the 10 potential sources they used in the past 30 days. The 10 individual sources were examined separately (text quoted in parentheses, to follow) and aggregated into 6 categories (bolded), based on previous work 34 : (1) physician ("got from one doctor" or "got from more than one doctor"), (2) stole/fake prescription ("took from friend or relative without asking," "wrote fake prescription," or "stole from doctor's office, clinic, hospital, or pharmacy"), (3) free from friend or relative ("got from friend or relative for free"), (4) purchased ("bought from friend or relative," "bought from drug dealer or other stranger," or "bought on the internet"), (5) other ("got some other way"), and (6) multiple sources (use of 2 or more sources).
For the analyses of substance use correlates of PO source categories (Table 4) , sources were coded to allow only one, mutually exclusive, response from the 6 larger categories above, whereas source data for other analyses were not mutually exclusive (ie, participants could be counted in multiple single source categories and in the multiple sources group).
Substance use disorder symptoms were assessed using pastyear DSM-IV SUD symptoms. 1 In the NSDUH, the 11 DSM-IV symptoms of substance abuse and substance dependence are assessed, and the 10 applicable DSM-5 SUD symptoms were retained, 2 legal problems (a DSM-IV criterion) were excluded, and craving, which was not assessed in the DSM-IV, was not available for inclusion. Prescription opioid use disorder symptom variables included both a variable for any symptoms and one for having 2 or more symptoms; alcohol, marijuana, heroin, cocaine, hallucinogen, inhalant, prescription stimulant, or prescription tranquilizer/ sedative SUD symptoms were assessed in the same fashion. Substance use disorder categories were chosen to highlight initial impairment or distress from opioid misuse (any symptoms 8 ) or symptoms consistent with the DSM-5 SUD diagnosis (2 or more symptoms 2 ), given the relative equality of SUD symptoms found elsewhere. 10, 14 Concurrent substance use included: past 30-day binge alcohol use (ie, 5 or more drinks for males and 4 or more drinks for females in a single occasion); past-year marijuana use; and, past-year polyprescription misuse (ie, endorsement of both pastyear PO misuse and at least one of past-year stimulant, tranquilizer, or sedative misuse).
Data analyses
Data were weighted, clustered on primary sampling units, and stratified appropriately. The Taylor series approximation 33, 44 was used, with adjusted degrees of freedom, to create robust variance estimates. All analyses used an adjusted person-level weight (weight/6) to account for the 6 years of NSDUH data used and creating nationally representative estimates.
Initial analyses used weighted cross-tabulations to estimate prevalence and 95% confidence intervals by age cohort of PO sources for misuse ( Table 1) , and lifetime, past-year and pastmonth PO misuse, PO misuse-related SUD symptoms, and nonopioid SUD symptoms ( Table 2) . Primary analyses used design-based Rao-Scott x 2 tests of homogeneity. 31 When the initial x 2 test was significant, post hoc pairwise comparisons using design-based logistic regression were used, with P values Bonferroni corrected for multiple comparisons. Secondary analyses used data from only adults aged 50 years and older and examined 3 outcomes: (1) sex differences in PO sources (Supplemental Table C , available online at http://links.lww.com/ PAIN/A569); (2) prevalence of POUD symptoms by PO source ( Table 3) ; and (3) the substance use correlates of PO sources ( Table 4) . As noted above, in the analyses of substance use correlates (Table 4) , sources were coded to allow only one, mutually exclusive, source, whereas source data for other analyses were not mutually exclusive (ie, participants could be counted in multiple single source categories and in the multiple sources group). All regression analyses included sex and race/ethnicity as control variables to create adjusted odds ratios. Analyses were performed in Stata 15.0 (StataCorp, 2017).
Results

Source of opioid medication for misuse by age group
Data on prevalence of PO misuse, POUD symptoms, and other SUD symptoms by age group are provided in the online-only Supplemental Table A (available online at http://links.lww.com/ PAIN/A569). Use prevalence of the 6 aggregated PO source categories, including use of multiple sources, and pairwise comparisons are captured in Table 2 ; online-only Supplemental Table B (available online at http://links.lww.com/PAIN/A569) includes data on the Prevalence of sources of opioid medication for misuse among those engaged in past-month prescription opioid misuse by age group. Table 2 , use of theft or a fake prescription to obtain POs for misuse generally decreased through the aging process, although a spike in theft/fake prescription source prevalence was seen in those aged 50 to 64 years. Obtaining a PO for misuse from a friend or relative for free demonstrated a nonlinear progression in prevalence through aging, with lower rates in adolescents (37%), followed by sharp elevations in young adults (57%) and those aged 26 to 34 years (58%), and then declines to the 65 and older group (23%). The 65 and older group had the lowest rates of obtaining POs from friends or relatives for free, and both they and adolescents had significantly lower rates than those in the 3 age groups covering 18 to 49 years. Adults aged 50 to 64 years were intermediate in prevalence (48%) and did not significantly differ from other age groups.
A similar pattern was observed in prevalence of purchases to obtain POs for misuse, with low rates in adolescents, a spike in the young adult and 26 to 34 age groups (37% and 34%, respectively), followed by progressive declines. Those aged 65 and older were again the least likely to purchase POs (9%). As captured in Supplemental Table B (available online at http://links. lww.com/PAIN/A569), use of the internet to purchase POs for misuse was rare across ages, with no significant differences were found.
The lowest prevalence rate of multiple source use was found in adults aged 65 years and older (5%), although they did not significantly differ from any other group. Adolescents had the second lowest prevalence rate (21%), followed closely by adults aged 50 to 64 years (24%). Use of "other" sources did not significantly differ between any age groups. Examination of sex differences in PO source within adults who were 50 years of age and older revealed no significant differences. The data on sex differences are captured in online-only Supplemental Table C (available online at http://links.lww.com/PAIN/A569).
Prescription opioid use disorder symptoms by opioid medication source in adults aged 50 years and older
In adults aged 50 years and older, use of 3 sets of PO sources was significantly associated with higher rates of POUD symptoms, as compared to those engaged in PO misuse but not using that source: physician sources (52%, P 5 0.03), purchases (68%, P 5 0.0003), and use of multiple sources (65%, P 5 0.01; Table 3 ). For physician sources, use of 1 physician seemed to primarily account for the significant difference, as shown in onlineonly Supplemental Table D (available online at Table 4 Sources of opioid medication for past-month misuse and substance-related correlates in adults aged 50 years and older. 
Substance-related correlates of opioid sources in adults aged 50 years and older
For these analyses (outlined Table 4 ), larger source categories were coded in a mutually exclusive fashion, allowing participants 50 years and older to be coded as using 1 specific source (eg, purchases) or multiple sources in the past month, but not both. Relatively few significant differences were found when comparing these mutually exclusive source groups to use of physician sources exclusively. Purchases were associated with elevated odds of past-year marijuana use and past-year polyprescription drug misuse (ie, misuse of opioids and at least 1 of stimulants, sedatives, or tranquilizers), and use of multiple sources was associated with elevated odds of past-year marijuana use. Those using "other" sources were less likely to have engaged in binge alcohol use in the past month than those using physician sources, and those obtaining POs for misuse from friends or relatives for free had lower odds of POUD symptoms than those using physician sources.
Discussion
These results strongly suggest that older adults, especially those 65 years of age and older, are a unique group in terms of PO misuse sources. These results also suggest that adults 50 years and older who use physician sources, purchases, or multiple sources had elevated levels of POUD symptoms, as compared to those not using those sources. Those 65 years and older had the highest use of physician sources, including use of one or multiple physicians, and the lowest prevalence of theft/fake prescription, purchases, obtaining the opioid for free from friends and relatives or multiple PO source use. Nearly half (47.7%) of older adults 65 years and older reported physicians as their source for misused POs. Those aged 50 to 64 years were somewhat intermediate between the 65 years and older cohort and those aged 35 to 49 years, on physician source use (39.2%) and use of other sources (eg, theft); conversely, the 50-to 64-year-old cohort were often more like those aged 35 to 49 years in terms of use of these sources. Adults who were 65 years of age and older had the lowest prevalence rates of PO misuse and PO or nonopioid SUD symptoms across any timeframe; adults aged 50 to 64 years were generally the second lowest prevalence group on these outcomes. Analyses restricted to the 50 years and older group indicated that use of purchases, physician, and multiple PO sources were associated with increased PO-related SUD symptom rates as compared to those not using the source. When compared with those obtaining POs for misuse from physician sources, use of a very limited set of sources increased odds of marijuana (purchases and multiple sources) or polyprescription misuse (purchases). This result may partially stem from the association between physician source and significantly higher rates of POUD symptoms among older adult PO misusers, vs those not using the source. Unlike adolescents using physician sources, with their lower odds of other substance use and lower odds of frequent PO misuse than those using nonphysician sources, 32 this work highlights older adults using physician sources as a higher-risk group.
These data also underline the increasing importance of clinician PO prescribing as a misuse source as individuals age.
Use of peer or family sources is found in roughly two-thirds or more of adults younger than 50 years engaged in past-month PO misuse (adolescents had a lower rate), whereas under one-third (30.2%) of adults aged 65 years and older did so. By contrast, nearly half (47.7%) of those aged 65 years and older used physician sources, whereas no more than 30% of those younger than 50 years did so. Increasing use of physician sources in older adults may reflect higher utilization of health care and a greater prevalence of chronic pain, 12, 21 joint replacement surgery, 19 and cancer, 18 all of which may involve PO therapy. Older adult use of physician sources provides prescribers an opportunity to carefully monitor patients for misuse and intervene in those with strong signals of misuse (eg, early refill requests and doctor shopping). Along with proper storage and disposal recommendations (eg, medication take-back efforts and mixing with coffee grounds in a sealed bag before disposing), monitoring and intervention efforts are necessary, given evidence of increased polypharmacy in older adults receiving POs for a pain-related diagnosis. 23 Monitoring should include POUD symptom screening, 39 as symptoms were elevated in those using 1 physician source, and some traditional misuse screening tools (eg, prescription drug monitoring databases) would not flag these individuals. The 2016 CDC guidelines for chronic pain-related opioid prescribing can help clinicians balance adequate pain management with appropriate PO oversight. 11 The guidelines recommend nonopioid treatment of chronic pain initially, and they emphasize the need for even greater caution and more frequent oversight when POs are prescribed to those 65 years and older, given this population's increased risks of consequences from PO use. 11 Careful monitoring and heightened screening, oversight, and (in cases of potential misuse) intervention are all crucial in adults aged 50 years and older, especially as use of physician sources was associated with a higher likelihood of PO-related SUD symptoms.
The relative lack of concurrent substance use correlates in older adults purchasing POs, using theft or fake prescriptions or using multiple sources for POs was notable. In adolescents 34 and young adults, 26 those using theft/fake prescriptions or purchases consistently had greater odds of binge alcohol, marijuana, and heavier opioid misuse than those using physician sources; furthermore, in young adults, individuals using multiple sources had greater odds of these risks than those using only physician sources. 26 The limited differences in concurrent substance use in older adults using different PO sources may signal that different processes promote PO misuse at different ages, with clustering of deviant behaviors (including PO misuse) in younger misusers and perhaps, greater use of POs to treat physical pain in older adults. Conversely, risk associated with sources may change through the aging process, such that those using physician sources may engage in greater risk behavior as they age. A third option is that longterm PO use may lead to neuroadaptations that produce reduced efficacy and tolerance 13 and result in PO-seeking behavior and misuse. Further work should investigate how aging interacts with long-term PO use, PO source selection, and risk engagement to clarify these processes.
Limitations
Six limitations of this work should be noted. First, the data are both cross-sectional and self-report in nature, so no causal inferences should be drawn and the possibility of self-report bias needs to be considered. Past work suggests that self-report of substance use is a reliable and valid method to assess such behavior, although some degree of underreporting and misclassification of participants is likely 16, 28 ; use of medication pictures, a variety of both trade and generic medication names, and ACASI self-interview methods should also reduce self-report bias for PO variables. 3, 4 Second, selfselection bias was also likely to have occurred, given that some of those selected for screening and a full interview refused participation. Third, the NSDUH does not assess pain or pain conditions, and given that the primary indication of opioid medication is analgesia, this is a limitation. Fourth, the wording of the question on medical sources in the NSDUH only specifically references "physician(s)," and those receiving POs from another prescribing clinician may not have been properly classified. Fifth, although the NSDUH makes extra efforts to sample older adults in assisted living or other controlled access dwellings, it is likely that older adults in nonhousehold settings were somewhat undersampled. 9 A final limitation is the relatively narrow timeframe of sampling for sources, with only those endorsing past-month opioid misuse sampled; other sources of information (eg, prescription drug monitoring programs) provide a longer timeframe for data, and the NSDUH timeframe limits comparisons with these sources.
Conclusions
These findings strongly suggest that older adults are a unique population in terms of PO misuse. Their pattern of sources for PO misuse is different than patterns seen in younger adults, with increasing use of physician sources in the 50-to 64-year group and the highest rates in those 65 years of age and older (47.7%). Older adults who misused opioids and obtained them from 1 physician had an increased likelihood of POUD symptoms, highlighting those using physician sources as a higher-risk subgroup. Those 65 years and older are roughly half as likely to use peer or family sources for misused opioids as those younger than 50 years. Furthermore, and as compared to adolescents or young adults, their pattern of substance use correlates is much less robust in those using purchases, theft, or multiple sources vs those using physician sources.
These results suggest measures that can limit older adult PO misuse, including education on proper medication storage and disposal, education on the risks of PO medical misuse (ie, misusing one's own prescription), heightened monitoring for signs of concurrent other substance and PO use, enhanced screening for potential SUDs, and heightened monitoring for behaviors associated with PO misuse in older adults. Also, the CDC guidelines for opioid use in chronic pain 11 can aid clinician decision making when considering POs for older adults; while not strictly contraindicated, the guidelines suggest use of nonopioid therapy before opioid initiation and urge cautious and judicious PO use in older adults, given their heightened potential for negative outcomes.
These findings indicate that the evolving literature on opioid misuse in young adults and adolescents cannot simply be applied to older adults. Although PO misuse prevalence rates were lowest in those 50 years and older, with the lowest rates in those 65 years and older, increasing numbers of such older adults engaged in opioid misuse, with greater potential consequences, are reason for concern about opioid misuse in older adults. 7, 29, 40 Combined with the evidence presented here that older adults engaged in opioid misuse differ significantly from younger individuals engaged in misuse, the elevated potential for opioid misuse consequences in this age group highlights the need for further research into opioid misuse in this understudied population.
